Literature DB >> 10356364

Expression of a Y559F mutant CSF-1 receptor in M1 myeloid cells: a role for Src kinases in CSF-1 receptor-mediated differentiation.

D C Marks1, X F Csar, N J Wilson, U Novak, A C Ward, V Kanagasundarum, B W Hoffmann, J A Hamilton.   

Abstract

We have established two M1 myeloid cell lines, M1/WT cells overexpressing the wild-type CSF-1 receptor and M1/Y559F cells expressing a specific tyrosine mutant. M1/WT cells differentiated in response to CSF-1, with a reduction in their proliferative capacity. CSF-1-mediated differentiation was partially abrogated in the M1/Y559F cells, with a less marked reduction in proliferative capacity. The Src tyrosine kinases c-Src, c-Yes, c-Fyn, and c-Hck were tyrosine phosphorylated in the M1/WT cells in response to CSF-1 and bound to the WT CSF-1R through their SH2 domains. Binding of the Src kinases to the CSF-1 receptor was greatly reduced in the M1/Y559F cells. CSF-1-mediated activation of STAT3 was also abrogated in the M1/Y559F cell line. Treatment of M1/WT cells with the Src family inhibitor PP2 resulted in an inhibition of CSF-1-mediated differentiation, equivalent to that observed in the M1/Y559F cells. These data suggest that the reduced Src binding observed in the M1/Y559F cells may contribute to their reduced ability to differentiate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10356364     DOI: 10.1006/mcbr.1999.0123

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  9 in total

1.  CSF-1-induced Src signaling can instruct monocytic lineage choice.

Authors:  Max Endele; Dirk Loeffler; Konstantinos D Kokkaliaris; Oliver Hilsenbeck; Stavroula Skylaki; Philipp S Hoppe; Axel Schambach; E Richard Stanley; Timm Schroeder
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

Review 2.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

3.  Colony-stimulating factor-1 (CSF-1) receptor-mediated macrophage differentiation in myeloid cells: a role for tyrosine 559-dependent protein phosphatase 2A (PP2A) activity.

Authors:  K A McMahon; N J Wilson; D C Marks; T L Beecroft; G A Whitty; J A Hamilton; X F Csar
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

4.  Profiling Y561-dependent and -independent substrates of CSF-1R in epithelial cells.

Authors:  Melodie L Knowlton; Laura M Selfors; Carolyn N Wrobel; Ting-Lei Gu; Bryan A Ballif; Steven P Gygi; Roberto Polakiewicz; Joan S Brugge
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 5.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

6.  A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling.

Authors:  Maddalena Cross; Xavier F Csar; Nicholas J Wilson; Gaël Manes; Theresa A Addona; Denese C Marks; Genevieve A Whitty; Keith Ashman; John A Hamilton
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

Review 7.  Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.

Authors:  Ashleigh R Poh; Robert J J O'Donoghue; Matthias Ernst
Journal:  Oncotarget       Date:  2015-06-30

8.  Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture.

Authors:  Carolyn N Wrobel; Jayanta Debnath; Eva Lin; Sean Beausoleil; Martine F Roussel; Joan S Brugge
Journal:  J Cell Biol       Date:  2004-04-26       Impact factor: 10.539

9.  High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1.

Authors:  Hanneke Wm van Laarhoven; Maarten F Bijlsma; Anne Steins; Madelaine G van Mackelenbergh; Amber P van der Zalm; Remy Klaassen; Bryan Serrels; Sandrine G Goris; Hemant M Kocher; Cynthia Waasdorp; Joan H de Jong; Cansu Tekin; Marc G Besselink; Olivier R Busch; Marc J van de Vijver; Joanne Verheij; Frederike Dijk; Geertjan van Tienhoven; Johanna W Wilmink; Jan Paul Medema
Journal:  EMBO Rep       Date:  2020-03-16       Impact factor: 8.807

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.